Literature DB >> 28341881

Birmingham vasculitis activity score at diagnosis is a significant predictor of relapse of polyarteritis nodosa.

Yoon-Jeong Oh1, Sung Soo Ahn1, Eun Seong Park1, Seung Min Jung1, Jason Jungsik Song1, Yong-Beom Park1, Sang-Won Lee2.   

Abstract

The objective of this study was to investigate whether clinical and laboratory data, Birmingham vasculitis activity score (BVAS) and five factor scores (FFS) at diagnosis could predict relapse in 30 patients with polyarteritis nodosa (PAN) having the follow-up duration for over 12 months. We reviewed the medical charts of 30 patients with PAN. We obtained clinical and laboratory data at diagnosis, and we compared them between the two groups based on relapse. The optimal cut-off values of BVAS and FFS (1996) at diagnosis to predict relapse were extrapolated. The mean age of patients (15 men) was 50.8 years, and the mean follow-up duration was 64.1 months. Nine patients (30.0%) had experience relapse after remission. Patients having relapse showed the higher frequency of weight loss and ocular symptoms and the less frequency of diastolic hypertension than those having not (p < 0.005 for all). On multivariate logistic regression analysis, weight loss was the only independent predictor of relapse, but on Cox Hazard model analysis, its statistical significance disappeared. The mean initial BVAS and FFS (1996) of patients in relapse group were higher than those of patients in no relapse group (p < 0.005 for all). Patients having initial BVAS over 13.5 and FFS (1996) over 1 exhibited significantly higher risk of relapse than those having not (RR 40.0 and RR 7.0, respectively). However, initial BVAS over 13.5 only remained significant in Kaplan-Meier survival analysis. In conclusion, BVAS over 13.5 at diagnosis was the only independent predictor of relapse of PAN.

Entities:  

Keywords:  Birmingham vasculitis activity score; Five factor scores; Polyarteritis nodosa; Relapse

Mesh:

Year:  2017        PMID: 28341881     DOI: 10.1007/s00296-017-3706-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  27 in total

Review 1.  Treatment of classic polyarteritis nodosa in 1999.

Authors:  L Guillevin
Journal:  Nephrol Dial Transplant       Date:  1999-09       Impact factor: 5.992

Review 2.  Polyarteritis nodosa: A contemporary overview.

Authors:  Armando De Virgilio; Antonio Greco; Giuseppe Magliulo; Andrea Gallo; Giovanni Ruoppolo; Michela Conte; Salvatore Martellucci; Marco de Vincentiis
Journal:  Autoimmun Rev       Date:  2016-02-13       Impact factor: 9.754

3.  Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database.

Authors:  Christian Pagnoux; Raphaèle Seror; Corneliu Henegar; Alfred Mahr; Pascal Cohen; Véronique Le Guern; Boris Bienvenu; Luc Mouthon; Loïc Guillevin
Journal:  Arthritis Rheum       Date:  2010-02

4.  Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients.

Authors:  M Gayraud; L Guillevin; P le Toumelin; P Cohen; F Lhote; P Casassus; B Jarrousse
Journal:  Arthritis Rheum       Date:  2001-03

Review 5.  Diagnosis and classification of polyarteritis nodosa.

Authors:  José Hernández-Rodríguez; Marco A Alba; Sergio Prieto-González; Maria C Cid
Journal:  J Autoimmun       Date:  2014-01-28       Impact factor: 7.094

6.  Circulating soluble adhesion molecules in patients with classical polyarteritis nodosa.

Authors:  B Coll-Vinent; J M Grau; A López-Soto; J Oristrell; C Font; X Bosch; E Mirapeix; A Urbano-Márquez; M C Cid
Journal:  Br J Rheumatol       Date:  1997-11

7.  Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients.

Authors:  Loïc Guillevin; Pascal Cohen; Alfred Mahr; Jean-Pierre Arène; Luc Mouthon; Xavier Puéchal; Edouard Pertuiset; Brigitte Gilson; Mohamed Hamidou; Patricia Lanoux; Alain Bruet; Marc Ruivard; Philippe Vanhille; Jean-François Cordier
Journal:  Arthritis Rheum       Date:  2003-02-15

8.  Clinical features of polyarteritis nodosa in Korea.

Authors:  Young Deok Bae; Hyo Jin Choi; Jung Chan Lee; Jeong Jin Park; Yun Jong Lee; Eun Bong Lee; Yeong Wook Song
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

9.  Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.

Authors:  Christian Pagnoux; Alfred Mahr; Mohamed A Hamidou; Jean-Jacques Boffa; Marc Ruivard; Jean-Pierre Ducroix; Xavier Kyndt; François Lifermann; Thomas Papo; Marc Lambert; José Le Noach; Mehdi Khellaf; Dominique Merrien; Xavier Puéchal; Stéphane Vinzio; Pascal Cohen; Luc Mouthon; Jean-François Cordier; Loïc Guillevin
Journal:  N Engl J Med       Date:  2008-12-25       Impact factor: 91.245

10.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts
Journal:  Arthritis Rheum       Date:  2013-01
View more
  3 in total

1.  HBsAg-negative and anti-HBc-positive in eosinophilic granulomatosis with polyangiitis: a retrospective pilot study.

Authors:  Sang-Won Lee; Do Young Kim; Sang Hoon Ahn; Yong-Beom Park; Kwang-Hyub Han; Jun Yong Park
Journal:  Rheumatol Int       Date:  2018-05-12       Impact factor: 2.631

2.  Red Blood Cell Distribution Width Can Predict Vasculitis Activity and Poor Prognosis in Granulomatosis with Polyangiitis.

Authors:  Ho Jae Kim; Juyoung Yoo; Seung Min Jung; Jason Jungsik Song; Yong Beom Park; Sang Won Lee
Journal:  Yonsei Med J       Date:  2018-03       Impact factor: 2.759

3.  Delta Neutrophil Index Is Associated with Vasculitis Activity and Risk of Relapse in ANCA-Associated Vasculitis.

Authors:  Juyoung Yoo; Sung Soo Ahn; Seung Min Jung; Jason Jungsik Song; Yong Beom Park; Sang Won Lee
Journal:  Yonsei Med J       Date:  2018-05       Impact factor: 2.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.